TY - JOUR
T1 - Neoadjuvant chemotherapy for breast cancer—background for the indication of locoregional treatment
AU - Krug, David
AU - Baumann, René
AU - Budach, Wilfried
AU - Dunst, Jürgen
AU - Feyer, Petra
AU - Fietkau, Rainer
AU - Haase, Wulf
AU - Harms, Wolfgang
AU - Hehr, Thomas
AU - Piroth, Marc D.
AU - Sedlmayer, Felix
AU - Souchon, Rainer
AU - Wenz, Frederik
AU - Sauer, Rolf
PY - 2018/9/1
Y1 - 2018/9/1
N2 - © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Neoadjuvant chemotherapy (NACT) has been widely adopted into the multidisciplinary management of breast cancer. The prognostic impact of treatment response has been clearly demonstrated. However, the impact of treatment response on the indication for adjuvant radiotherapy is unclear. This review summarizes important implications of NACT and treatment response on the risk of recurrence and locoregional multidisciplinary management from the standpoint of radiation oncology.
AB - © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Neoadjuvant chemotherapy (NACT) has been widely adopted into the multidisciplinary management of breast cancer. The prognostic impact of treatment response has been clearly demonstrated. However, the impact of treatment response on the indication for adjuvant radiotherapy is unclear. This review summarizes important implications of NACT and treatment response on the risk of recurrence and locoregional multidisciplinary management from the standpoint of radiation oncology.
UR - http://www.scopus.com/inward/record.url?scp=85049583566&partnerID=8YFLogxK
U2 - 10.1007/s00066-018-1329-8
DO - 10.1007/s00066-018-1329-8
M3 - Scientific review articles
C2 - 29974132
AN - SCOPUS:85049583566
SN - 0179-7158
VL - 194
SP - 797
EP - 805
JO - Strahlentherapie und Onkologie
JF - Strahlentherapie und Onkologie
IS - 9
ER -
